Trials / Withdrawn
WithdrawnNCT03921476
Acne and Mood: Impact of Treatment on Depression, Anxiety, and Sexual Function
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- —
Summary
This study seeks to examine if there is any relationship between spironolactone use prescribed for acne vulgaris and depression, anxiety, and/or sexual function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Online survey | Online survey completion through Northwestern's REDCap |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2019-04-19
- Last updated
- 2020-10-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03921476. Inclusion in this directory is not an endorsement.